Kiniksa Pharmaceuticals International Insider Sold Shares Worth $3,389,975, According to a Recent SEC Filing

10:20 AM EST, 11/04/2026 (MT Newswires) -- Mark Ragosa, Chief Financial Officer, on November 02, 2026, sold 36,783 shares in Kiniksa Pharmaceuticals International (KNSA) for $3,389,975. Following the Form 4 filing with the SEC, Ragosa has control over a total of 20,854 Class A ordinary shares of the company, with 20,854 shares held directly. Sales were effected pursuant to a 10b5-1 plan executed on July 29. SEC Filing: https://www.sec.gov/Archives/edgar/data/1730430/000183545826000014/xslF345X05/form4-11032026_111136.xml Price: 93.58, Change: +0.29, Percent Change: +0.31